Hydroxyethylmethacrylate (HEMA) and Di-HEMA Trimethylhexyl Dicarbamate (Di-HEMA TMHDC) are two colorless viscous liquids that readily polymerize when exposed to UV-light. Because of their physical properties, these monomers are typically used in nail enhancement products. The skin sensitization potential of these cosmetic ingredients raised concerns since 2016. The restriction of HEMA and Di-HEMA TMHDC to professional […]
Regulatory
Part I I recently started working for Biorius with the responsibility of managing chemical regulations questions. I quickly noticed that there was a question for which there are many divergent opinions around, a lot of hearsay and very little substantiated answers. And this question was: How the REACH regulation applies to cosmetics? While you’ll find […]
China will implement a new legislation called Cosmetic Supervision and Administration Regulation (CSAR) on January 1, 2021. After the US, China is the world’s second-largest cosmetic market and those changes will have a huge impact for many companies around the globe. The actual text of reference is Regulation Concerning the Hygiene Supervision over Cosmetics, in […]
The United Kingdom (UK) formally left the European Union (EU) on January 31, 2020. Northern Ireland and Great Britain will follow different routes to maintain a cosmetic regulation in their respective territory. Northern Ireland (NI) will continue to apply European Cosmetic regulation (EC) No 1223/2009, to cosmetic products manufactured or sold in NI, as mentioned […]
Several regulatory developments related to endocrine disruptors are ongoing in the EU. Among them, the ECHA committees (European Chemicals Agency) have the duty to review ingredients suspected to be endocrine disruptors and that may have serious effects on human health or the environment. The first significant cosmetic ingredient to be reviewed in this regard was […]
The WHO defines an endocrine disruptor as ‘an exogenous substance or mixture that alters function(s) of the endocrine system and consequently causes adverse health effects in an intact organism, or its progeny, or (sub)populations’. This definition has been retained by the European Union, which started a number of developments to better regulate these substances in […]
What are they and their regulatory status For now and for the sake of argument, lets ignore the controversy surrounding the term “cosmeceuticals” (more on this later) as proteins and peptides as used in cosmetics conveniently fall under such an umbrella term. The term “cosmeceuticals” was coined more than 25 years ago by Professor Albert […]
